We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $5.12B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
+8.13%
1 Year Est. Return
+314.02%
3 Year Est. Return
+1,498.66%
5 Year Est. Return
+2,457.67%
10 Year Est. Return
+48,821.41%
AUM
$988M
AUM Growth
-$31.3M
Cap. Flow
-$56.5M
Cap. Flow %
-5.72%
Top 10 Hldgs %
45.25%
Holding
164
New
47
Increased
25
Reduced
25
Closed
38

Top Buys

Rank Stock Value
1
OTIC
Otonomy, Inc.
OTIC
+$16.6M
2
AEGR
Aegerion Pharmaceuticals
AEGR
+$11.4M
3
ARWR icon
Arrowhead Research
ARWR
+$11.3M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$10.4M
5
EPZM
Epizyme, Inc
EPZM
+$7.5M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$37M
2
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$24.1M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$21.9M
4
SHPG
Shire pic
SHPG
+$21.2M
5
INSM icon
Insmed
INSM
+$18.1M

Sector Composition

Rank Sector Weight
1 Healthcare 79.83%
2 Financials 0.18%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMSG
101
DELISTED
Amsurg Corp
AMSG
$118K 0.01%
2,348
+368
+19% +$18.4K
GTIV
102
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$118K 0.01%
7,052
– –
GTS
103
DELISTED
Triple-S Management Corporation
GTS
$117K 0.01%
6,181
– –
CYH icon
104
Community Health Systems
CYH
$382M
$116K 0.01%
+2,569
New +$107K
UHS icon
105
Universal Health Services
UHS
$10.2B
$115K 0.01%
1,101
-1,135
-51% -$121K
SMA
106
DELISTED
SYMMETRY MEDICAL INC
SMA
$112K 0.01%
11,148
– –
CNC icon
107
Centene
CNC
$30.5B
$111K 0.01%
5,344
-234,656
-98% -$4.52M
CRL icon
108
Charles River Laboratories
CRL
$11.3B
$111K 0.01%
1,860
– –
HRC
109
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$110K 0.01%
+2,657
New +$111K
SCLN
110
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
$110K 0.01%
+16,035
New +$96.1K
ELV icon
111
Elevance Health
ELV
$81.5B
$108K 0.01%
+901
New +$103K
SEM
112
DELISTED
Select Medical
SEM
$108K 0.01%
+16,734
New +$129K
AET
113
DELISTED
Aetna Inc
AET
$106K 0.01%
1,308
-130,000
-99% -$10.6M
LGND icon
114
Ligand Pharmaceuticals
LGND
$5.77B
$105K 0.01%
3,599
-41,033
-92% -$1.36M
ITGR icon
115
Integer Holdings
ITGR
$3.39B
$104K 0.01%
+2,681
New +$115K
MCK icon
116
McKesson
MCK
$104B
$103K 0.01%
527
-3
-0.6% -$577
EXAC
117
DELISTED
Exactech Inc
EXAC
$102K 0.01%
4,464
– –
MRGE
118
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$96K 0.01%
43,478
– –
AIQ
119
DELISTED
Alliance Healthcare Services
AIQ
$79K 0.01%
+3,500
New +$96.8K
PDLI
120
DELISTED
PDL BioPharma, Inc.
PDLI
$76K 0.01%
10,183
– –
ICEL
121
DELISTED
CELLULAR DYNAMICS INTL INC COM STK (WI)
ICEL
$1K ﹤0.01%
+164
New +$1.82K
BLRX
122
BioLineRX
BLRX
$12M
– –
-276
Closed -$345K
CPRX
123
DELISTED
Catalyst Pharmaceutical
CPRX
– –
-1,500,000
Closed -$3.79M
ENSG icon
124
The Ensign Group
ENSG
$10.6B
– –
-7,502
Closed -$109K
EXAS
125
DELISTED
Exact Sciences
EXAS
– –
-901,250
Closed -$15.3M
3 4
5
6 7

Similar funds

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return

Perceptive Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Perceptive Advisors held 164 positions worth $988M, down 3.1% from $1.02B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Perceptive Advisors withdrew a net $56.5M in Q3 2014, closing 38 positions and reducing 25 holdings. Its most notable exit was QUESTCOR PHARMA INC, an estimated $37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 81% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Perceptive Advisors opened a new position in Otonomy, Inc. worth $20.1M.

  • Perceptive Advisors's largest Q3 2014 buy was Otonomy, Inc.: 837,400 shares worth $20.1M.
  • Perceptive Advisors added most to Arrowhead Research in Q3 2014, an estimated $11.3M increase.
  • Perceptive Advisors's biggest Q3 2014 reduction was Taro Pharmaceutical Industries Ltd., cutting an estimated $24.1M.
  • Perceptive Advisors fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $37M.
  • Perceptive Advisors's ten largest holdings make up 45% of its $988M portfolio in Q3 2014.
  • Perceptive Advisors opened 47 new positions and closed 38 in Q3 2014.
  • Perceptive Advisors's portfolio value fell 3.1% quarter-over-quarter to $988M.

Based on Perceptive Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.